vancomycin has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, A; Dufresne, C; Gonzalez del Val, A; Graham, A; Pelaez, F; Platas, G; Valentino, D; Young, K; Zink, D | 1 |
| Bruckner, HW | 1 |
2 other study(ies) available for vancomycin and Leukemia L 1210
| Article | Year |
|---|---|
Illudinic acid, a novel illudane sesquiterpene antibiotic.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Leukemia L1210; Mice; Microbial Sensitivity Tests; Sesquiterpenes; Staphylococcus aureus; Tumor Cells, Cultured | 1997 |
Effect of antibiotics on mice treated with cyclophosphamide.
Topics: Animals; Anti-Bacterial Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Drug Interactions; Escherichia coli; Gentamicins; Humans; Intestines; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neomycin; Penicillins; Species Specificity; Vancomycin | 1976 |